Skip to content

CorMedix CRMD Net Income

Net Income at other companies

Pfizer logo
PfizerPFE
$2.69B-9.4%
Merck & Co. logo
Merck & Co.MRK
-$4.24B-183%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$41M+36.0%
ITG
Integer HoldingsITGR
$16.51M+173%
IAR
Integra LifeSciencesIART
-$4.62M+81.7%
Abbott logo
AbbottABT
$1.08B-18.7%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's net income?
CorMedix (CRMD) reported net income of $38.6M in Q1 2026.
How has CorMedix's net income changed year-over-year?
CorMedix's net income increased by 87.0% year-over-year, from $20.64M to $38.6M.
What is the long-term trend for CorMedix's net income?
Over 3 years (2021 to 2025), CorMedix's net income has grown at a 79.5% compound annual growth rate (CAGR), from -$28.21M to $163.06M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.